Phoenix Thera-Lase for Treating Chronic Pain in Patients Taking Opioid on a PRN Basis
Unknown statusNot applicableNCT02964000
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Hypothesis: Use of high level vs low level cold laser treatments will reduce chronic pain and the need for PRN opioid-containing analgesic medications. Secondary Hypothesis: High level (vs low level) laser treatments will increase the patients level of physical activity and quality of sleep.
Study details
- Official title
- Adjunct Use of the Phoenix Thera-Lase for Treating Chronic Pain in Patients Taking Opioid-containing Medication on a PRN Basis
- Conditions
- Interventions
- Device: Low level 1 Watt
- Device: Phoenix Thera-Lase System 42
- Device: Phoenix Thera-Lase System 74
- Sponsor
- Phoenix Thera-lase Systems, LLC
- Start date
- 2016-11
- Primary completion
- 2017-12
- Sex
- All
- Age range
- from 25 Years to 65 Years
- Results posted
- No results posted in this snapshot
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Male or female patients * 25-65 years of age * taking oral opiate-containing analgesic medication on a PRN * patient with chronic pain related to an accident, injury or major surgery occurring within the past three years * Patients with a potentially treatable pain condition * Patient wiling to complete a daily diary for recording their pain score, activity level, quality of sleep and all pain-related medications for the three-week study period Exclusion Criteria: * Use of any opioid-containing pain medications for more than three years * History of alcohol or drug abuse, or drug-seeking behavior * Previous treatment for drug abuse in detox center or hospital * Current psychiatric condition which require centrally- active medications * Current excessive use of alcohol * Any unstable medical conditions (e.g. coronary artery disease, hepato-renal or pulmonary disease) * Patients not capable of consenting for themselves * Pregnant women * Women of child bearing potential not using acceptable birth control methods.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT02964000